☰

Anthony Davenport - Publications

Affiliations: 
Medicine University of Cambridge, Cambridge, England, United Kingdom 
Area:
ClinicalPharmacology
Tree Info Similar researchers PubMed Report error

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Alexander SPH, Christopoulos A, Davenport AP, Kelly E, Mathie AA, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Davies JA, Abbracchio MP, Abraham G, Agoulnik A, Alexander W, et al. The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors. British Journal of Pharmacology. S23-S144. PMID 38123151 DOI: 10.1111/bph.16177  0.735
2023 Williams TL, Macrae RGC, Kuc RE, Brown AJH, Maguire JJ, Davenport AP. Expanding the apelin receptor pharmacological toolbox using novel fluorescent ligands. Frontiers in Endocrinology. 14: 1139121. PMID 36967803 DOI: 10.3389/fendo.2023.1139121  0.322
2022 Abraham GR, Nyimanu D, Kuc RE, Maguire JJ, Davenport AP, Hoole SP. Trans-myocardial Extraction of Endothelin-1 Correlates with Increased Microcirculatory Resistance following Percutaneous Coronary Intervention. Journal of Interventional Cardiology. 2022: 9154048. PMID 36262459 DOI: 10.1155/2022/9154048  0.687
2022 Macrae RGC, Colzani MT, Williams TL, Bayraktar S, Kuc RE, Pullinger AL, Bernard WG, Robinson EL, Davenport EE, Maguire JJ, Sinha S, Davenport AP. Inducible apelin receptor knockdown reduces differentiation efficiency and contractility of hESC-derived cardiomyocytes. Cardiovascular Research. PMID 36239923 DOI: 10.1093/cvr/cvac065  0.324
2022 Nyimanu D, Chapman FA, Gallacher PJ, Kuc RE, Williams TL, Newby DE, Maguire JJ, Davenport AP, Dhaun N. Apelin is expressed throughout the human kidney, is elevated in chronic kidney disease & associates independently with decline in kidney function. British Journal of Clinical Pharmacology. PMID 35748053 DOI: 10.1111/bcp.15446  0.724
2021 Williams TL, Strachan G, Macrae RGC, Kuc RE, Nyimanu D, Paterson AL, Sinha S, Maguire JJ, Davenport AP. Differential expression in humans of the viral entry receptor ACE2 compared with the short deltaACE2 isoform lacking SARS-CoV-2 binding sites. Scientific Reports. 11: 24336. PMID 34934117 DOI: 10.1038/s41598-021-03731-9  0.724
2021 Alexander SP, Christopoulos A, Davenport AP, Kelly E, Mathie A, Peters JA, Veale EL, Armstrong JF, Faccenda E, Harding SD, Pawson AJ, Southan C, Davies JA, Abbracchio MP, Alexander W, et al. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein-coupled receptors. British Journal of Pharmacology. 178: S27-S156. PMID 34529832 DOI: 10.1111/bph.15538  0.735
2021 Nyimanu D, Kay RG, Kuc RE, Brown AJH, Gribble FM, Maguire JJ, Davenport AP. In vitro metabolism of synthetic Elabela/Toddler (ELA-32) peptide in human plasma and kidney homogenates analyzed with mass spectrometry and validation of endogenous peptide quantification in tissues by ELISA. Peptides. 170642. PMID 34455010 DOI: 10.1016/j.peptides.2021.170642  0.736
2021 Chapman FA, Nyimanu D, Maguire JJ, Davenport AP, Newby DE, Dhaun N. The therapeutic potential of apelin in kidney disease. Nature Reviews. Nephrology. PMID 34389827 DOI: 10.1038/s41581-021-00461-z  0.732
2021 Williams TL, Colzani MT, Macrae RGC, Robinson EL, Bloor S, Greenwood EJD, Zhan JR, Strachan G, Kuc RE, Nyimanu D, Maguire JJ, Lehner PJ, Sinha S, Davenport AP. Human embryonic stem cell-derived cardiomyocyte platform screens inhibitors of SARS-CoV-2 infection. Communications Biology. 4: 926. PMID 34326460 DOI: 10.1038/s42003-021-02453-y  0.693
2020 Read C, Nyimanu D, Yang P, Kuc RE, Williams TL, Fitzpatrick CM, Foster R, Glen RC, Maguire JJ, Davenport AP. The G Protein Biased Small Molecule Apelin Agonist CMF-019 is Disease Modifying in Endothelial Cell Apoptosis and Induces Vasodilatation Without Desensitisation . Frontiers in Pharmacology. 11: 588669. PMID 33716722 DOI: 10.3389/fphar.2020.588669  0.775
2020 Owen NE, Nyimanu D, Kuc RE, Upton PD, Morrell NW, Alexander GJ, Maguire JJ, Davenport AP. Plasma levels of apelin are reduced in patients with liver fibrosis and cirrhosis but are not correlated with circulating levels of bone morphogenetic protein 9 and 10. Peptides. 170440. PMID 33171278 DOI: 10.1016/j.peptides.2020.170440  0.711
2019 Nyimanu D, Kay RG, Sulentic P, Kuc RE, Ambery P, Jermutus L, Reimann F, Gribble FM, Cheriyan J, Maguire JJ, Davenport AP. Development and validation of an LC-MS/MS method for detection and quantification of in vivo derived metabolites of [Pyr]apelin-13 in humans. Scientific Reports. 9: 19934. PMID 31882594 DOI: 10.1038/S41598-019-56157-9  0.712
2019 Read C, Nyimanu D, Williams TL, Huggins DJ, Sulentic P, Macrae RGC, Yang P, Glen RC, Maguire JJ, Davenport AP. International Union of Basic and Clinical Pharmacology. CVII. Structure and Pharmacology of the Apelin Receptor with a Recommendation that Elabela/Toddler Is a Second Endogenous Peptide Ligand. Pharmacological Reviews. 71: 467-502. PMID 31492821 DOI: 10.1124/Pr.119.017533  0.785
2019 Nyimanu D, Kuc RE, Williams TL, Bednarek M, Ambery P, Jermutus L, Maguire JJ, Davenport AP. Apelin-36-[L28A] and Apelin-36-[L28C(30kDa-PEG)] peptides that improve diet induced obesity are G Protein Biased Ligands at the Apelin Receptor. Peptides. 170139. PMID 31472173 DOI: 10.1016/J.Peptides.2019.170139  0.757
2019 Read C, Yang P, Kuc RE, Nyimanu D, Williams TL, Glen RC, Holt LJ, Arulanantham H, Smart A, Davenport AP, Maguire JJ. Apelin peptides linked to anti-serum albumin domain antibodies retain affinity in vitro and are efficacious receptor agonists in vivo. Basic & Clinical Pharmacology & Toxicology. PMID 30901161 DOI: 10.1111/Bcpt.13227  0.757
2019 Yang P, Read C, Kuc RE, Nyimanu D, Williams TL, Crosby A, Buonincontri G, Southwood M, Sawiak SJ, Morrell NW, Davenport AP, Maguire JJ. A novel cyclic biased agonist of the apelin receptor, MM07, is disease modifying in the rat monocrotaline model of pulmonary arterial hypertension. British Journal of Pharmacology. PMID 30710493 DOI: 10.1111/Bph.14603  0.781
2019 Williams T, O’Flaherty E, Nyimanu D, Macrae R, Currinn H, Brown J, Brown A, Strachan G, Gräf S, Morrell N, Maguire J, Davenport A, Kuc RE. BS46 High content high resolution confocal imaging to characterise mutations in the apelin receptor identified in patients from the 100,000 genomes project Heart. 105. DOI: 10.1136/Heartjnl-2019-Bcs.207  0.747
2019 O’Flaherty E, Williams T, Nyimanu D, Macrae R, Currinn H, Brown J, Brown A, Strachan G, Maguire J, Davenport A. BS16 A novel fluorescent apelin ligand tracks apelin receptor internalisation Heart. DOI: 10.1136/Heartjnl-2019-Bcs.179  0.736
2018 Davenport A, Kuc R, Southan C, Maguire J. New drugs and emerging therapeutic targets in the endothelin signaling pathway and prospects for personalized precision medicine. Physiological Research. 67. PMID 29947527 DOI: 10.33549/Physiolres.933872  0.424
2018 Kennedy AJ, Davenport AP. International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function. Pharmacological Reviews. 70: 174-196. PMID 29279348 DOI: 10.1124/pr.116.013177  0.34
2017 Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R, Upton PD, Crosby A, Sawiak SJ, Carpenter TA, Glen RC, Morrell NW, Maguire JJ, Davenport AP. Elabela/Toddler is an Endogenous Agonist of the Apelin APJ Receptor in the Adult Cardiovascular System, and Exogenous Administration of the Peptide Compensates for the Downregulation of its Expression in Pulmonary Arterial Hypertension. Circulation. PMID 28137936 DOI: 10.1161/Circulationaha.116.023218  0.607
2016 Kennedy AJ, Yang P, Read C, Kuc RE, Yang L, Taylor EJ, Taylor CW, Maguire JJ, Davenport AP. Chemerin Elicits Potent Constrictor Actions via Chemokine-Like Receptor 1 (CMKLR1), not G-Protein-Coupled Receptor 1 (GPR1), in Human and Rat Vasculature. Journal of the American Heart Association. 5. PMID 27742615 DOI: 10.1161/Jaha.116.004421  0.596
2016 Read C, Fitzpatrick CM, Yang P, Kuc RE, Maguire JJ, Glen RC, Foster RE, Davenport AP. Cardiac action of the first G protein biased small molecule apelin agonist. Biochemical Pharmacology. PMID 27475715 DOI: 10.1016/J.Bcp.2016.07.018  0.568
2016 Davenport AP, Hyndman KA, Dhaun N, Southan C, Kohan DE, Pollock JS, Pollock DM, Webb DJ, Maguire JJ. Endothelin. Pharmacological Reviews. 68: 357-418. PMID 26956245 DOI: 10.1124/pr.115.011833  0.367
2015 Yang P, Maguire JJ, Davenport AP. Apelin, Elabela/Toddler, and biased agonists as novel therapeutic agents in the cardiovascular system. Trends in Pharmacological Sciences. PMID 26143239 DOI: 10.1016/j.tips.2015.06.002  0.352
2015 Shaikh LH, Zhou J, Teo AE, Garg S, Neogi SG, Figg N, Yeo GS, Yu H, Maguire JJ, Zhao W, Bennett MR, Azizan EA, Davenport AP, McKenzie G, Brown MJ. LGR5 Activates Noncanonical Wnt Signaling and Inhibits Aldosterone Production in the Human Adrenal. The Journal of Clinical Endocrinology and Metabolism. 100: E836-44. PMID 25915569 DOI: 10.1210/Jc.2015-1734  0.377
2015 Brame AL, Maguire JJ, Yang P, Dyson A, Torella R, Cheriyan J, Singer M, Glen RC, Wilkinson IB, Davenport AP. Design, characterization, and first-in-human study of the vascular actions of a novel biased apelin receptor agonist. Hypertension. 65: 834-40. PMID 25712721 DOI: 10.1161/Hypertensionaha.114.05099  0.307
2013 Azizan EA, Poulsen H, Tuluc P, Zhou J, Clausen MV, Lieb A, Maniero C, Garg S, Bochukova EG, Zhao W, Shaikh LH, Brighton CA, Teo AE, Davenport AP, Dekkers T, et al. Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension. Nature Genetics. 45: 1055-60. PMID 23913004 DOI: 10.1038/Ng.2716  0.348
2012 Maguire J, Kuc R, Pell V, Davenport A. 12 Pharmacology of Human ETA and ETB Receptor Signalling VIA G-Protein and Beta-Arrestin Pathways Heart. 98. DOI: 10.1136/Heartjnl-2012-302951.012  0.392
2011 Maguire JJ, Kirby HR, Mead EJ, Kuc RE, d'Anglemont de Tassigny X, Colledge WH, Davenport AP. Inotropic action of the puberty hormone kisspeptin in rat, mouse and human: cardiovascular distribution and characteristics of the kisspeptin receptor. Plos One. 6: e27601. PMID 22132116 DOI: 10.1371/journal.pone.0027601  0.332
2011 Jones KL, Maguire JJ, Davenport AP. Chemokine receptor CCR5: from AIDS to atherosclerosis. British Journal of Pharmacology. 162: 1453-69. PMID 21133894 DOI: 10.1111/J.1476-5381.2010.01147.X  0.407
2010 Kirby HR, Maguire JJ, Colledge WH, Davenport AP. International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function. Pharmacological Reviews. 62: 565-78. PMID 21079036 DOI: 10.1124/pr.110.002774  0.342
2010 Pitkin SL, Maguire JJ, Bonner TI, Davenport AP. International Union of Basic and Clinical Pharmacology. LXXIV. Apelin receptor nomenclature, distribution, pharmacology, and function. Pharmacological Reviews. 62: 331-42. PMID 20605969 DOI: 10.1124/pr.110.002949  0.307
2010 Davenport A. Management of acute kidney injury in liver disease. Contributions to Nephrology. 165: 197-205. PMID 20427970 DOI: 10.1159/000313759  0.3
2009 Vachiery J, Davenport A. The endothelin system in pulmonary and renal vasculopathy: les liaisons dangereuses. European Respiratory Review. 18: 260-271. PMID 20956151 DOI: 10.1183/09059180.00005709  0.383
2009 Mitchell JD, Maguire JJ, Davenport AP. Emerging pharmacology and physiology of neuromedin U and the structurally related peptide neuromedin S. British Journal of Pharmacology. 158: 87-103. PMID 19519756 DOI: 10.1111/J.1476-5381.2009.00252.X  0.425
2009 Maguire JJ, Parker WA, Foord SM, Bonner TI, Neubig RR, Davenport AP. International Union of Pharmacology. LXXII. Recommendations for trace amine receptor nomenclature. Pharmacological Reviews. 61: 1-8. PMID 19325074 DOI: 10.1124/pr.109.001107  0.308
2005 Maguire JJ, Davenport AP. Regulation of vascular reactivity by established and emerging GPCRs. Trends in Pharmacological Sciences. 26: 448-54. PMID 16054240 DOI: 10.1016/j.tips.2005.07.007  0.312
2005 Edvinsson L, Uddman E, Wackenfors A, Davenport A, Longmore J, Malmsjö M. Triptan-induced contractile (5-HT1B receptor) responses in human cerebral and coronary arteries: relationship to clinical effect. Clinical Science (London, England : 1979). 109: 335-42. PMID 15853772 DOI: 10.1042/Cs20050016  0.323
2005 Kleinz MJ, Skepper JN, Davenport AP. Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regulatory Peptides. 126: 233-40. PMID 15664671 DOI: 10.1016/j.regpep.2004.10.019  0.307
2004 Wiley KE, Davenport AP. CRF2 receptors are highly expressed in the human cardiovascular system and their cognate ligands urocortins 2 and 3 are potent vasodilators. British Journal of Pharmacology. 143: 508-14. PMID 15381637 DOI: 10.1038/sj.bjp.0705985  0.31
2003 Katugampola S, Davenport A. Emerging roles for orphan G-protein-coupled receptors in the cardiovascular system. Trends in Pharmacological Sciences. 24: 30-5. PMID 12498728 DOI: 10.1016/S0165-6147(02)00007-X  0.454
2002 Katugampola SD, Kuc RE, Maguire JJ, Davenport AP. G-protein-coupled receptors in human atherosclerosis: comparison of vasoconstrictors (endothelin and thromboxane) with recently de-orphanized (urotensin-II, apelin and ghrelin) receptors. Clinical Science (London, England : 1979). 103: 171S-175S. PMID 12193079 DOI: 10.1042/CS103S171S  0.341
1993 Karet F, Plumpton C, Davenport A. Characterisation of Immunoreactive Endothelin in Human kidney by RP-HPLC and RIA Clinical Science. 84. DOI: 10.1042/Cs084006Pb  0.309
1992 Harcombe A, Persidis A, Davenport A, Kuc R, Plumpton C, Weissberg P. Isolation of Endothelin Receptors from Human Atrium by Mobility Shift Analysis Clinical Science. 83. DOI: 10.1042/Cs083019Pb  0.365
Show low-probability matches.